Key result
In patients undergoing thoracic endovascular aortic repair, preexisting chronic kidney disease was a significant independent predictor of in-hospital mortality and major adverse events (OR 10.33).
Why the study?
TEVAR was not widely practiced locally until 2017, and predictors of in-hospital and short-term outcomes in this setting were needed to compare with local and international data.
Population
52 adult patients undergoing TEVAR for aortic aneurysm and aortic syndrome
Comparison
Predictors of in-hospital mortality and major adverse events
Design
Single-center retrospective analysis
Follow-up
1 year
Authors
Loading...
CKD predicts higher in-hospital mortality after TEVAR; hypothesis-generating for risk stratification and requires prospective validation.
Cohort (n=52)
No
Odds Ratio: 10.33 (95% CI 1.1069–96.462)
p-value: p=0.040
In patients undergoing TEVAR, increasing weight, preexisting chronic kidney disease, and single-stage debranching are independent predictors of in-hospital mortality and major adverse events.
Alegado-Aseniero et al. (2024) conducted a cohort in Aortic aneurysm and aortic syndrome (n=52). Preexisting chronic kidney disease vs. No chronic kidney disease was evaluated on In-hospital mortality and major adverse events (MAEs) (OR 10.33, 95% CI 1.1069-96.462, p=0.040). In patients undergoing thoracic endovascular aortic repair, preexisting chronic kidney disease was a significant independent predictor of in-hospital mortality and major adverse events (OR 10.33).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: